510(k) SUMMARY OF SAFETY AND EFFECTIVENESS

This summary of 510(k) safety and effectiveness information is being submitted in
accordance with the requirements of the Safe Medical Devices Act (SMDA) of 1990 and
21 CFR 807.92. All data included in this document is accurate and complete to the best of
KSEA’s knowledge.
Applicant: Karl Storz Endoscopy - America, Inc. NOV 4 2O?

600 Corporate Pointe Drive

Culver City, CA 90230

(310) 338-8100
Contact: James A. Lee

Regulatory Affairs Specialist
Device Identification: © Common Name:

Electrosurgical Generator

Trade Name: (optional)

The KSEA Autocon II 400 Electrosurgical Generator
Indication: The Autocon {1 400 Electrosurgical Generator is intended for use by
qualified surgeons to provide a high frequency (HF) electrical current for cutting and
coagulating tissue during open and endoscopic surgeries, including general, plastic,
urological, neurological, and gynecologic procedures.
Device Description: The Autocon II 400 consists of a generator, a dual pedal foot switch.
and a power cord. The footswitch activates the power for cutting and coagulation. The
Autocon II 400 is able to provide either monopolar or bipolar modes for cutting and
coagulation. It can be linked to Karl Storz SCB.
Substantial Equivalence: The KSEA Autocon II 400 Electrosurgical Generator is
substantially equivalent to the predicate devices since the basic design, dimensions, safety
features, and intended uses are similar. The minor differences between the KSEA
Autocon II 400 Electrosurgical Generator and the predicate devices raise no new issues of
safety and effectiveness, as these differences have no effect on the performance, function
or intended use of these devices.
Signed: ” Uh. fe

Japfés A. Lee, Ph.D.
Senior Regulatory Affairs Specialist
cue

entene, .
é Z DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
Ca remmsnmamomcsaness tnt
er Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
NOV 4 2002
Kar] Storz Endoscopy-America, Inc
James A. Lee
Senior Regulatory Affairs Specialist .
: 600 Corporate Pointe :

Culver City, California 90230-7600 :
Re: K021467

Trade/Device Name: Autocon II 400 Electrosurgical Generator

Regulation Number: 878.4400

Regulation Name: Electrosurgical probe

Regulatory Class: Class IJ

Product Cede: GEl

Dated: September 11, 2002

Received: September 12, 2002
Dear Mr. Lee:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801): good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 —Mr. James A. Lee
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device to
: proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and
additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of
Compliance at (301)'594-4659. Additionally, for questions on the promotion and advertising of
your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the
regulation entitled, “Misbranding by reference to premarket notification” (21 CFR Part 807.97).
Other general information on your responsibilities under the Act may be obtained from the Division
of Smal! Manufacturers, International and Consumer Assistance at its toll-free number (800)
638-2041 or (301) 443-6597 or at its Internet address
http://www. fda.gov/cedrh/dsma/dsmamain. html

Sincerely yours,

Priam ©: Povo

oY Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure

PRETREATMENT EE EE here ae PERRY ee ee ESAT ek ees “ a Seis
wa SRR. de SOR SE ee on mad Suda gp dart ae SP UEEMESE Se a cerd tye SUM Dale es hull
SO Kk oglyel
, 510(k) Number (if known): Not yet assigned.
. Device Name: Autocon II 400 Electrosurgical Generator
: Indications for Use: The Autocon II 400 Electrosurgical Generator is intended for use by
qualified ‘surgeons to provide a high frequency (HF) electrical current for cutting and
coagulating tissue during open and endoscopic surgeries, including general, plastic,
urological, neurological, and gynecologic procedures. - , ;
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE
IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use: Vv OR Over-The-Counter Use:
(Per 21 CFR 801.109)
(Optional Format 1-2-96)
@ivision Sign-OfD)
Division of Gener2}, Restorative
and Neurologic“: Devices
510(k) Number KOBL46 7. oug

